nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—BCL2—esophageal cancer	0.267	0.543	CbGaD
Ibuprofen—PTGS1—esophageal cancer	0.109	0.222	CbGaD
Ibuprofen—PTGS2—esophageal cancer	0.0626	0.127	CbGaD
Ibuprofen—ABCB1—esophageal cancer	0.0532	0.108	CbGaD
Ibuprofen—SLC22A11—Methotrexate—esophageal cancer	0.0339	0.146	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—esophageal cancer	0.0316	0.136	CbGbCtD
Ibuprofen—PTGS2—Cisplatin—esophageal cancer	0.0286	0.123	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—esophageal cancer	0.0254	0.109	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—esophageal cancer	0.0226	0.0977	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—esophageal cancer	0.0197	0.0851	CbGbCtD
Ibuprofen—CYP2C9—Capecitabine—esophageal cancer	0.0193	0.0832	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—esophageal cancer	0.0137	0.0593	CbGbCtD
Ibuprofen—ALB—Methotrexate—esophageal cancer	0.0117	0.0505	CbGbCtD
Ibuprofen—UGT2B4—pericardium—esophageal cancer	0.0105	0.163	CbGeAlD
Ibuprofen—CYP2C9—Cisplatin—esophageal cancer	0.00972	0.0419	CbGbCtD
Ibuprofen—ABCB1—Cisplatin—esophageal cancer	0.00943	0.0407	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—esophageal cancer	0.00612	0.0264	CbGbCtD
Ibuprofen—CFTR—exocrine gland—esophageal cancer	0.00271	0.0423	CbGeAlD
Ibuprofen—FABP2—epithelium—esophageal cancer	0.00258	0.0404	CbGeAlD
Ibuprofen—FABP2—digestive system—esophageal cancer	0.00196	0.0307	CbGeAlD
Ibuprofen—BCL2—neck—esophageal cancer	0.00171	0.0267	CbGeAlD
Ibuprofen—THBD—epithelium—esophageal cancer	0.00165	0.0258	CbGeAlD
Ibuprofen—THBD—bronchus—esophageal cancer	0.00163	0.0254	CbGeAlD
Ibuprofen—THBD—smooth muscle tissue—esophageal cancer	0.00159	0.0249	CbGeAlD
Ibuprofen—Procarbazine—CYP1B1—esophageal cancer	0.00147	0.381	CrCbGaD
Ibuprofen—THBD—trachea—esophageal cancer	0.00146	0.0228	CbGeAlD
Ibuprofen—THBD—digestive system—esophageal cancer	0.00126	0.0196	CbGeAlD
Ibuprofen—UGT1A3—digestive system—esophageal cancer	0.00121	0.019	CbGeAlD
Ibuprofen—CFTR—epithelium—esophageal cancer	0.00118	0.0184	CbGeAlD
Ibuprofen—BCL2—epithelium—esophageal cancer	0.00116	0.0182	CbGeAlD
Ibuprofen—CFTR—bronchus—esophageal cancer	0.00116	0.0181	CbGeAlD
Ibuprofen—PLAT—bronchus—esophageal cancer	0.00115	0.0179	CbGeAlD
Ibuprofen—FABP2—lymph node—esophageal cancer	0.00112	0.0175	CbGeAlD
Ibuprofen—BCL2—smooth muscle tissue—esophageal cancer	0.00112	0.0175	CbGeAlD
Ibuprofen—CXCL8—bronchus—esophageal cancer	0.00106	0.0166	CbGeAlD
Ibuprofen—UGT2B4—lung—esophageal cancer	0.00106	0.0165	CbGeAlD
Ibuprofen—THBD—lung—esophageal cancer	0.00105	0.0164	CbGeAlD
Ibuprofen—CFTR—trachea—esophageal cancer	0.00104	0.0163	CbGeAlD
Ibuprofen—CXCL8—smooth muscle tissue—esophageal cancer	0.00104	0.0162	CbGeAlD
Ibuprofen—PLAT—trachea—esophageal cancer	0.00103	0.0161	CbGeAlD
Ibuprofen—CXCL8—trachea—esophageal cancer	0.000953	0.0149	CbGeAlD
Ibuprofen—CFTR—digestive system—esophageal cancer	0.000896	0.014	CbGeAlD
Ibuprofen—BCL2—digestive system—esophageal cancer	0.000885	0.0138	CbGeAlD
Ibuprofen—UGT1A9—digestive system—esophageal cancer	0.000865	0.0135	CbGeAlD
Ibuprofen—PPARG—neck—esophageal cancer	0.000822	0.0128	CbGeAlD
Ibuprofen—CFTR—lung—esophageal cancer	0.000749	0.0117	CbGeAlD
Ibuprofen—PLAT—lung—esophageal cancer	0.000739	0.0116	CbGeAlD
Ibuprofen—BCL2—lung—esophageal cancer	0.000739	0.0116	CbGeAlD
Ibuprofen—THBD—lymph node—esophageal cancer	0.000718	0.0112	CbGeAlD
Ibuprofen—UGT2B7—digestive system—esophageal cancer	0.000697	0.0109	CbGeAlD
Ibuprofen—CXCL8—lung—esophageal cancer	0.000685	0.0107	CbGeAlD
Ibuprofen—SLC22A11—digestive system—esophageal cancer	0.000679	0.0106	CbGeAlD
Ibuprofen—UGT1A1—digestive system—esophageal cancer	0.000593	0.00927	CbGeAlD
Ibuprofen—PPARG—epithelium—esophageal cancer	0.000559	0.00874	CbGeAlD
Ibuprofen—PPARG—smooth muscle tissue—esophageal cancer	0.000539	0.00842	CbGeAlD
Ibuprofen—BCL2—lymph node—esophageal cancer	0.000506	0.00791	CbGeAlD
Ibuprofen—PLAT—lymph node—esophageal cancer	0.000506	0.00791	CbGeAlD
Ibuprofen—ABCC4—bronchus—esophageal cancer	0.0005	0.00782	CbGeAlD
Ibuprofen—Carprofen—PTGS1—esophageal cancer	0.000474	0.123	CrCbGaD
Ibuprofen—CXCL8—lymph node—esophageal cancer	0.000468	0.00732	CbGeAlD
Ibuprofen—SLCO2B1—digestive system—esophageal cancer	0.000436	0.00682	CbGeAlD
Ibuprofen—ABCC1—bronchus—esophageal cancer	0.000426	0.00666	CbGeAlD
Ibuprofen—PPARG—digestive system—esophageal cancer	0.000425	0.00665	CbGeAlD
Ibuprofen—SLCO1A2—digestive system—esophageal cancer	0.000401	0.00627	CbGeAlD
Ibuprofen—ABCC4—digestive system—esophageal cancer	0.000386	0.00604	CbGeAlD
Ibuprofen—ABCC1—trachea—esophageal cancer	0.000383	0.00598	CbGeAlD
Ibuprofen—SLCO2B1—lung—esophageal cancer	0.000364	0.00569	CbGeAlD
Ibuprofen—PPARG—lung—esophageal cancer	0.000355	0.00555	CbGeAlD
Ibuprofen—SLCO1A2—lung—esophageal cancer	0.000335	0.00524	CbGeAlD
Ibuprofen—ABCC4—lung—esophageal cancer	0.000323	0.00504	CbGeAlD
Ibuprofen—CYP2C19—digestive system—esophageal cancer	0.000321	0.00502	CbGeAlD
Ibuprofen—PTGS1—epithelium—esophageal cancer	0.000299	0.00467	CbGeAlD
Ibuprofen—Suprofen—PTGS1—esophageal cancer	0.000293	0.0761	CrCbGaD
Ibuprofen—PTGS1—smooth muscle tissue—esophageal cancer	0.000288	0.0045	CbGeAlD
Ibuprofen—PTGS2—epithelium—esophageal cancer	0.000286	0.00447	CbGeAlD
Ibuprofen—PTGS2—bronchus—esophageal cancer	0.000281	0.0044	CbGeAlD
Ibuprofen—PTGS2—smooth muscle tissue—esophageal cancer	0.000275	0.0043	CbGeAlD
Ibuprofen—ABCC1—lung—esophageal cancer	0.000275	0.0043	CbGeAlD
Ibuprofen—Carprofen—PTGS2—esophageal cancer	0.000271	0.0704	CrCbGaD
Ibuprofen—PTGS1—trachea—esophageal cancer	0.000264	0.00413	CbGeAlD
Ibuprofen—PTGS2—trachea—esophageal cancer	0.000253	0.00395	CbGeAlD
Ibuprofen—Fenoprofen—PTGS1—esophageal cancer	0.000252	0.0656	CrCbGaD
Ibuprofen—SLCO2B1—lymph node—esophageal cancer	0.000249	0.00389	CbGeAlD
Ibuprofen—CYP2C9—digestive system—esophageal cancer	0.000249	0.00389	CbGeAlD
Ibuprofen—PPARG—lymph node—esophageal cancer	0.000243	0.0038	CbGeAlD
Ibuprofen—Naproxen—PTGS1—esophageal cancer	0.00023	0.0597	CrCbGaD
Ibuprofen—ALB—lymph node—esophageal cancer	0.000228	0.00356	CbGeAlD
Ibuprofen—PTGS1—digestive system—esophageal cancer	0.000227	0.00355	CbGeAlD
Ibuprofen—ABCC4—lymph node—esophageal cancer	0.000221	0.00345	CbGeAlD
Ibuprofen—PTGS2—digestive system—esophageal cancer	0.000217	0.0034	CbGeAlD
Ibuprofen—PTGS1—lung—esophageal cancer	0.00019	0.00297	CbGeAlD
Ibuprofen—ABCC1—lymph node—esophageal cancer	0.000188	0.00294	CbGeAlD
Ibuprofen—Mouth ulceration—Methotrexate—esophageal cancer	0.000188	0.00215	CcSEcCtD
Ibuprofen—Urinary tract disorder—Cisplatin—esophageal cancer	0.000187	0.00215	CcSEcCtD
Ibuprofen—Liver function test abnormal—Capecitabine—esophageal cancer	0.000187	0.00214	CcSEcCtD
Ibuprofen—Urethral disorder—Cisplatin—esophageal cancer	0.000186	0.00213	CcSEcCtD
Ibuprofen—Gynaecomastia—Methotrexate—esophageal cancer	0.000186	0.00212	CcSEcCtD
Ibuprofen—Abdominal pain upper—Capecitabine—esophageal cancer	0.000185	0.00211	CcSEcCtD
Ibuprofen—Hypokalaemia—Capecitabine—esophageal cancer	0.000184	0.00211	CcSEcCtD
Ibuprofen—Visual impairment—Cisplatin—esophageal cancer	0.000183	0.00209	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000182	0.00208	CcSEcCtD
Ibuprofen—PTGS2—lung—esophageal cancer	0.000182	0.00284	CbGeAlD
Ibuprofen—Sepsis—Methotrexate—esophageal cancer	0.00018	0.00206	CcSEcCtD
Ibuprofen—Gastritis—Capecitabine—esophageal cancer	0.000179	0.00205	CcSEcCtD
Ibuprofen—Tinnitus—Cisplatin—esophageal cancer	0.000177	0.00203	CcSEcCtD
Ibuprofen—ABCB1—epithelium—esophageal cancer	0.000177	0.00276	CbGeAlD
Ibuprofen—Lymphadenopathy—Methotrexate—esophageal cancer	0.000177	0.00202	CcSEcCtD
Ibuprofen—Abdominal distension—Capecitabine—esophageal cancer	0.000176	0.00201	CcSEcCtD
Ibuprofen—Dysphagia—Capecitabine—esophageal cancer	0.000175	0.002	CcSEcCtD
Ibuprofen—Influenza—Capecitabine—esophageal cancer	0.000175	0.002	CcSEcCtD
Ibuprofen—Asthma—Capecitabine—esophageal cancer	0.000175	0.002	CcSEcCtD
Ibuprofen—Bronchospasm—Capecitabine—esophageal cancer	0.000172	0.00197	CcSEcCtD
Ibuprofen—Photosensitivity—Methotrexate—esophageal cancer	0.000172	0.00196	CcSEcCtD
Ibuprofen—Polyuria—Methotrexate—esophageal cancer	0.000172	0.00196	CcSEcCtD
Ibuprofen—Immune system disorder—Cisplatin—esophageal cancer	0.000171	0.00196	CcSEcCtD
Ibuprofen—Mediastinal disorder—Cisplatin—esophageal cancer	0.000171	0.00196	CcSEcCtD
Ibuprofen—Arrhythmia—Cisplatin—esophageal cancer	0.00017	0.00194	CcSEcCtD
Ibuprofen—Bronchitis—Capecitabine—esophageal cancer	0.000168	0.00192	CcSEcCtD
Ibuprofen—Alopecia—Cisplatin—esophageal cancer	0.000168	0.00192	CcSEcCtD
Ibuprofen—Abdominal discomfort—Capecitabine—esophageal cancer	0.000168	0.00192	CcSEcCtD
Ibuprofen—Hepatic failure—Methotrexate—esophageal cancer	0.000168	0.00192	CcSEcCtD
Ibuprofen—Suprofen—PTGS2—esophageal cancer	0.000167	0.0435	CrCbGaD
Ibuprofen—Pancytopenia—Capecitabine—esophageal cancer	0.000166	0.0019	CcSEcCtD
Ibuprofen—Malnutrition—Cisplatin—esophageal cancer	0.000165	0.00189	CcSEcCtD
Ibuprofen—Erythema—Cisplatin—esophageal cancer	0.000165	0.00189	CcSEcCtD
Ibuprofen—Flurbiprofen—PTGS1—esophageal cancer	0.000165	0.0428	CrCbGaD
Ibuprofen—Neutropenia—Capecitabine—esophageal cancer	0.000163	0.00187	CcSEcCtD
Ibuprofen—Dysuria—Capecitabine—esophageal cancer	0.000163	0.00187	CcSEcCtD
Ibuprofen—Renal failure acute—Methotrexate—esophageal cancer	0.000163	0.00187	CcSEcCtD
Ibuprofen—Flatulence—Cisplatin—esophageal cancer	0.000163	0.00186	CcSEcCtD
Ibuprofen—Atenolol—ABCB1—esophageal cancer	0.00016	0.0415	CrCbGaD
Ibuprofen—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00016	0.00183	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00016	0.00183	CcSEcCtD
Ibuprofen—Visual disturbance—Methotrexate—esophageal cancer	0.000159	0.00182	CcSEcCtD
Ibuprofen—Muscle spasms—Cisplatin—esophageal cancer	0.000159	0.00182	CcSEcCtD
Ibuprofen—Weight decreased—Capecitabine—esophageal cancer	0.000158	0.00181	CcSEcCtD
Ibuprofen—Hyperglycaemia—Capecitabine—esophageal cancer	0.000158	0.00181	CcSEcCtD
Ibuprofen—Pneumonia—Capecitabine—esophageal cancer	0.000157	0.00179	CcSEcCtD
Ibuprofen—ABCB1—trachea—esophageal cancer	0.000156	0.00244	CbGeAlD
Ibuprofen—Vision blurred—Cisplatin—esophageal cancer	0.000156	0.00178	CcSEcCtD
Ibuprofen—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000156	0.00178	CcSEcCtD
Ibuprofen—Depression—Capecitabine—esophageal cancer	0.000155	0.00178	CcSEcCtD
Ibuprofen—Tremor—Cisplatin—esophageal cancer	0.000155	0.00177	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000155	0.00177	CcSEcCtD
Ibuprofen—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000154	0.00176	CcSEcCtD
Ibuprofen—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000154	0.00176	CcSEcCtD
Ibuprofen—Ill-defined disorder—Cisplatin—esophageal cancer	0.000153	0.00176	CcSEcCtD
Ibuprofen—Renal failure—Capecitabine—esophageal cancer	0.000153	0.00175	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000153	0.00175	CcSEcCtD
Ibuprofen—Myocardial infarction—Capecitabine—esophageal cancer	0.000153	0.00175	CcSEcCtD
Ibuprofen—Anaemia—Cisplatin—esophageal cancer	0.000153	0.00175	CcSEcCtD
Ibuprofen—Stomatitis—Capecitabine—esophageal cancer	0.000152	0.00174	CcSEcCtD
Ibuprofen—Jaundice—Capecitabine—esophageal cancer	0.000152	0.00174	CcSEcCtD
Ibuprofen—Conjunctivitis—Capecitabine—esophageal cancer	0.000152	0.00173	CcSEcCtD
Ibuprofen—Urinary tract infection—Capecitabine—esophageal cancer	0.000152	0.00173	CcSEcCtD
Ibuprofen—Malaise—Cisplatin—esophageal cancer	0.000149	0.00171	CcSEcCtD
Ibuprofen—Haematuria—Capecitabine—esophageal cancer	0.000149	0.0017	CcSEcCtD
Ibuprofen—Leukopenia—Cisplatin—esophageal cancer	0.000148	0.00169	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000147	0.00169	CcSEcCtD
Ibuprofen—Epistaxis—Capecitabine—esophageal cancer	0.000147	0.00168	CcSEcCtD
Ibuprofen—Agranulocytosis—Capecitabine—esophageal cancer	0.000145	0.00167	CcSEcCtD
Ibuprofen—Fenoprofen—PTGS2—esophageal cancer	0.000144	0.0375	CrCbGaD
Ibuprofen—Convulsion—Cisplatin—esophageal cancer	0.000143	0.00164	CcSEcCtD
Ibuprofen—Mood swings—Methotrexate—esophageal cancer	0.000143	0.00163	CcSEcCtD
Ibuprofen—Myalgia—Cisplatin—esophageal cancer	0.000141	0.00161	CcSEcCtD
Ibuprofen—Haemoglobin—Capecitabine—esophageal cancer	0.000141	0.00161	CcSEcCtD
Ibuprofen—Rhinitis—Capecitabine—esophageal cancer	0.00014	0.00161	CcSEcCtD
Ibuprofen—Anxiety—Cisplatin—esophageal cancer	0.00014	0.0016	CcSEcCtD
Ibuprofen—Haemorrhage—Capecitabine—esophageal cancer	0.00014	0.0016	CcSEcCtD
Ibuprofen—Hepatitis—Capecitabine—esophageal cancer	0.00014	0.0016	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00014	0.0016	CcSEcCtD
Ibuprofen—Liver function test abnormal—Methotrexate—esophageal cancer	0.000139	0.00159	CcSEcCtD
Ibuprofen—Discomfort—Cisplatin—esophageal cancer	0.000139	0.00159	CcSEcCtD
Ibuprofen—Pharyngitis—Capecitabine—esophageal cancer	0.000139	0.00159	CcSEcCtD
Ibuprofen—Urinary tract disorder—Capecitabine—esophageal cancer	0.000138	0.00158	CcSEcCtD
Ibuprofen—Oedema peripheral—Capecitabine—esophageal cancer	0.000138	0.00158	CcSEcCtD
Ibuprofen—Urethral disorder—Capecitabine—esophageal cancer	0.000137	0.00157	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000136	0.00155	CcSEcCtD
Ibuprofen—Anaphylactic shock—Cisplatin—esophageal cancer	0.000135	0.00154	CcSEcCtD
Ibuprofen—Oedema—Cisplatin—esophageal cancer	0.000135	0.00154	CcSEcCtD
Ibuprofen—Visual impairment—Capecitabine—esophageal cancer	0.000135	0.00154	CcSEcCtD
Ibuprofen—ABCB1—digestive system—esophageal cancer	0.000134	0.0021	CbGeAlD
Ibuprofen—Infection—Cisplatin—esophageal cancer	0.000134	0.00153	CcSEcCtD
Ibuprofen—Erythema multiforme—Capecitabine—esophageal cancer	0.000132	0.00151	CcSEcCtD
Ibuprofen—Nervous system disorder—Cisplatin—esophageal cancer	0.000132	0.00151	CcSEcCtD
Ibuprofen—Thrombocytopenia—Cisplatin—esophageal cancer	0.000132	0.00151	CcSEcCtD
Ibuprofen—Tachycardia—Cisplatin—esophageal cancer	0.000132	0.00151	CcSEcCtD
Ibuprofen—Naproxen—PTGS2—esophageal cancer	0.000131	0.0341	CrCbGaD
Ibuprofen—Skin disorder—Cisplatin—esophageal cancer	0.000131	0.0015	CcSEcCtD
Ibuprofen—Tinnitus—Capecitabine—esophageal cancer	0.00013	0.00149	CcSEcCtD
Ibuprofen—Hyperhidrosis—Cisplatin—esophageal cancer	0.00013	0.00149	CcSEcCtD
Ibuprofen—Asthma—Methotrexate—esophageal cancer	0.00013	0.00149	CcSEcCtD
Ibuprofen—PTGS1—lymph node—esophageal cancer	0.00013	0.00203	CbGeAlD
Ibuprofen—Eosinophilia—Methotrexate—esophageal cancer	0.000129	0.00147	CcSEcCtD
Ibuprofen—Anorexia—Cisplatin—esophageal cancer	0.000129	0.00147	CcSEcCtD
Ibuprofen—Pancreatitis—Methotrexate—esophageal cancer	0.000128	0.00146	CcSEcCtD
Ibuprofen—Immune system disorder—Capecitabine—esophageal cancer	0.000126	0.00145	CcSEcCtD
Ibuprofen—Mediastinal disorder—Capecitabine—esophageal cancer	0.000126	0.00144	CcSEcCtD
Ibuprofen—Hypotension—Cisplatin—esophageal cancer	0.000126	0.00144	CcSEcCtD
Ibuprofen—Chills—Capecitabine—esophageal cancer	0.000126	0.00144	CcSEcCtD
Ibuprofen—Arrhythmia—Capecitabine—esophageal cancer	0.000125	0.00143	CcSEcCtD
Ibuprofen—Abdominal discomfort—Methotrexate—esophageal cancer	0.000125	0.00143	CcSEcCtD
Ibuprofen—PTGS2—lymph node—esophageal cancer	0.000124	0.00194	CbGeAlD
Ibuprofen—Alopecia—Capecitabine—esophageal cancer	0.000124	0.00142	CcSEcCtD
Ibuprofen—Pancytopenia—Methotrexate—esophageal cancer	0.000124	0.00141	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000123	0.00141	CcSEcCtD
Ibuprofen—Mental disorder—Capecitabine—esophageal cancer	0.000123	0.0014	CcSEcCtD
Ibuprofen—Malnutrition—Capecitabine—esophageal cancer	0.000122	0.00139	CcSEcCtD
Ibuprofen—Erythema—Capecitabine—esophageal cancer	0.000122	0.00139	CcSEcCtD
Ibuprofen—Dysuria—Methotrexate—esophageal cancer	0.000122	0.00139	CcSEcCtD
Ibuprofen—Neutropenia—Methotrexate—esophageal cancer	0.000122	0.00139	CcSEcCtD
Ibuprofen—Paraesthesia—Cisplatin—esophageal cancer	0.000121	0.00139	CcSEcCtD
Ibuprofen—Dyspnoea—Cisplatin—esophageal cancer	0.00012	0.00138	CcSEcCtD
Ibuprofen—Flatulence—Capecitabine—esophageal cancer	0.00012	0.00137	CcSEcCtD
Ibuprofen—Erectile dysfunction—Methotrexate—esophageal cancer	0.00012	0.00137	CcSEcCtD
Ibuprofen—Dysgeusia—Capecitabine—esophageal cancer	0.000119	0.00137	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000119	0.00136	CcSEcCtD
Ibuprofen—Decreased appetite—Cisplatin—esophageal cancer	0.000117	0.00134	CcSEcCtD
Ibuprofen—Muscle spasms—Capecitabine—esophageal cancer	0.000117	0.00134	CcSEcCtD
Ibuprofen—Pneumonia—Methotrexate—esophageal cancer	0.000117	0.00134	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000116	0.00133	CcSEcCtD
Ibuprofen—Drowsiness—Methotrexate—esophageal cancer	0.000116	0.00133	CcSEcCtD
Ibuprofen—Depression—Methotrexate—esophageal cancer	0.000116	0.00132	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000115	0.00132	CcSEcCtD
Ibuprofen—Vision blurred—Capecitabine—esophageal cancer	0.000115	0.00131	CcSEcCtD
Ibuprofen—Tremor—Capecitabine—esophageal cancer	0.000114	0.00131	CcSEcCtD
Ibuprofen—Renal failure—Methotrexate—esophageal cancer	0.000114	0.00131	CcSEcCtD
Ibuprofen—Stomatitis—Methotrexate—esophageal cancer	0.000113	0.00129	CcSEcCtD
Ibuprofen—Ill-defined disorder—Capecitabine—esophageal cancer	0.000113	0.00129	CcSEcCtD
Ibuprofen—Conjunctivitis—Methotrexate—esophageal cancer	0.000113	0.00129	CcSEcCtD
Ibuprofen—Anaemia—Capecitabine—esophageal cancer	0.000113	0.00129	CcSEcCtD
Ibuprofen—ABCB1—lung—esophageal cancer	0.000112	0.00176	CbGeAlD
Ibuprofen—Sweating—Methotrexate—esophageal cancer	0.000111	0.00127	CcSEcCtD
Ibuprofen—Feeling abnormal—Cisplatin—esophageal cancer	0.000111	0.00127	CcSEcCtD
Ibuprofen—Haematuria—Methotrexate—esophageal cancer	0.000111	0.00127	CcSEcCtD
Ibuprofen—Malaise—Capecitabine—esophageal cancer	0.00011	0.00126	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00011	0.00126	CcSEcCtD
Ibuprofen—Epistaxis—Methotrexate—esophageal cancer	0.000109	0.00125	CcSEcCtD
Ibuprofen—Vertigo—Capecitabine—esophageal cancer	0.000109	0.00125	CcSEcCtD
Ibuprofen—Syncope—Capecitabine—esophageal cancer	0.000109	0.00125	CcSEcCtD
Ibuprofen—Leukopenia—Capecitabine—esophageal cancer	0.000109	0.00125	CcSEcCtD
Ibuprofen—Agranulocytosis—Methotrexate—esophageal cancer	0.000108	0.00124	CcSEcCtD
Ibuprofen—Palpitations—Capecitabine—esophageal cancer	0.000108	0.00123	CcSEcCtD
Ibuprofen—Loss of consciousness—Capecitabine—esophageal cancer	0.000107	0.00123	CcSEcCtD
Ibuprofen—Cough—Capecitabine—esophageal cancer	0.000106	0.00122	CcSEcCtD
Ibuprofen—Hypertension—Capecitabine—esophageal cancer	0.000105	0.0012	CcSEcCtD
Ibuprofen—Haemoglobin—Methotrexate—esophageal cancer	0.000105	0.0012	CcSEcCtD
Ibuprofen—Haemorrhage—Methotrexate—esophageal cancer	0.000104	0.00119	CcSEcCtD
Ibuprofen—Hepatitis—Methotrexate—esophageal cancer	0.000104	0.00119	CcSEcCtD
Ibuprofen—Arthralgia—Capecitabine—esophageal cancer	0.000104	0.00119	CcSEcCtD
Ibuprofen—Myalgia—Capecitabine—esophageal cancer	0.000104	0.00119	CcSEcCtD
Ibuprofen—Pharyngitis—Methotrexate—esophageal cancer	0.000103	0.00118	CcSEcCtD
Ibuprofen—Anxiety—Capecitabine—esophageal cancer	0.000103	0.00118	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000103	0.00118	CcSEcCtD
Ibuprofen—Urinary tract disorder—Methotrexate—esophageal cancer	0.000103	0.00118	CcSEcCtD
Ibuprofen—Discomfort—Capecitabine—esophageal cancer	0.000102	0.00117	CcSEcCtD
Ibuprofen—Urethral disorder—Methotrexate—esophageal cancer	0.000102	0.00117	CcSEcCtD
Ibuprofen—Dry mouth—Capecitabine—esophageal cancer	0.000101	0.00116	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—esophageal cancer	0.0001	0.00115	CcSEcCtD
Ibuprofen—Confusional state—Capecitabine—esophageal cancer	0.0001	0.00115	CcSEcCtD
Ibuprofen—Oedema—Capecitabine—esophageal cancer	9.94e-05	0.00114	CcSEcCtD
Ibuprofen—Hypersensitivity—Cisplatin—esophageal cancer	9.94e-05	0.00114	CcSEcCtD
Ibuprofen—Infection—Capecitabine—esophageal cancer	9.88e-05	0.00113	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—esophageal cancer	9.85e-05	0.00113	CcSEcCtD
Ibuprofen—Shock—Capecitabine—esophageal cancer	9.78e-05	0.00112	CcSEcCtD
Ibuprofen—Nervous system disorder—Capecitabine—esophageal cancer	9.75e-05	0.00112	CcSEcCtD
Ibuprofen—Thrombocytopenia—Capecitabine—esophageal cancer	9.73e-05	0.00111	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—esophageal cancer	9.71e-05	0.00111	CcSEcCtD
Ibuprofen—Tachycardia—Capecitabine—esophageal cancer	9.7e-05	0.00111	CcSEcCtD
Ibuprofen—Asthenia—Cisplatin—esophageal cancer	9.68e-05	0.00111	CcSEcCtD
Ibuprofen—Skin disorder—Capecitabine—esophageal cancer	9.66e-05	0.00111	CcSEcCtD
Ibuprofen—Hyperhidrosis—Capecitabine—esophageal cancer	9.61e-05	0.0011	CcSEcCtD
Ibuprofen—Anorexia—Capecitabine—esophageal cancer	9.48e-05	0.00108	CcSEcCtD
Ibuprofen—Flurbiprofen—PTGS2—esophageal cancer	9.41e-05	0.0245	CrCbGaD
Ibuprofen—Immune system disorder—Methotrexate—esophageal cancer	9.41e-05	0.00108	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—esophageal cancer	9.39e-05	0.00107	CcSEcCtD
Ibuprofen—Chills—Methotrexate—esophageal cancer	9.35e-05	0.00107	CcSEcCtD
Ibuprofen—Hypotension—Capecitabine—esophageal cancer	9.29e-05	0.00106	CcSEcCtD
Ibuprofen—Diarrhoea—Cisplatin—esophageal cancer	9.23e-05	0.00106	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—esophageal cancer	9.21e-05	0.00105	CcSEcCtD
Ibuprofen—Mental disorder—Methotrexate—esophageal cancer	9.13e-05	0.00104	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—esophageal cancer	9.07e-05	0.00104	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—esophageal cancer	9.07e-05	0.00104	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Capecitabine—esophageal cancer	9.06e-05	0.00104	CcSEcCtD
Ibuprofen—Insomnia—Capecitabine—esophageal cancer	8.99e-05	0.00103	CcSEcCtD
Ibuprofen—Paraesthesia—Capecitabine—esophageal cancer	8.93e-05	0.00102	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—esophageal cancer	8.88e-05	0.00102	CcSEcCtD
Ibuprofen—Dyspnoea—Capecitabine—esophageal cancer	8.86e-05	0.00101	CcSEcCtD
Ibuprofen—Dyspepsia—Capecitabine—esophageal cancer	8.75e-05	0.001	CcSEcCtD
Ibuprofen—Decreased appetite—Capecitabine—esophageal cancer	8.64e-05	0.000989	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Capecitabine—esophageal cancer	8.58e-05	0.000982	CcSEcCtD
Ibuprofen—Vomiting—Cisplatin—esophageal cancer	8.58e-05	0.000982	CcSEcCtD
Ibuprofen—Fatigue—Capecitabine—esophageal cancer	8.57e-05	0.000981	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—esophageal cancer	8.55e-05	0.000978	CcSEcCtD
Ibuprofen—Rash—Cisplatin—esophageal cancer	8.5e-05	0.000973	CcSEcCtD
Ibuprofen—Constipation—Capecitabine—esophageal cancer	8.5e-05	0.000973	CcSEcCtD
Ibuprofen—Dermatitis—Cisplatin—esophageal cancer	8.5e-05	0.000972	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—esophageal cancer	8.41e-05	0.000963	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—esophageal cancer	8.38e-05	0.000959	CcSEcCtD
Ibuprofen—Feeling abnormal—Capecitabine—esophageal cancer	8.19e-05	0.000938	CcSEcCtD
Ibuprofen—Malaise—Methotrexate—esophageal cancer	8.18e-05	0.000936	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—esophageal cancer	8.15e-05	0.000933	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Capecitabine—esophageal cancer	8.13e-05	0.000931	CcSEcCtD
Ibuprofen—Leukopenia—Methotrexate—esophageal cancer	8.12e-05	0.000929	CcSEcCtD
Ibuprofen—Nausea—Cisplatin—esophageal cancer	8.01e-05	0.000917	CcSEcCtD
Ibuprofen—Cough—Methotrexate—esophageal cancer	7.91e-05	0.000906	CcSEcCtD
Ibuprofen—Urticaria—Capecitabine—esophageal cancer	7.9e-05	0.000904	CcSEcCtD
Ibuprofen—Abdominal pain—Capecitabine—esophageal cancer	7.86e-05	0.0009	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—esophageal cancer	7.86e-05	0.000899	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—esophageal cancer	7.72e-05	0.000884	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—esophageal cancer	7.72e-05	0.000884	CcSEcCtD
Ibuprofen—ABCB1—lymph node—esophageal cancer	7.68e-05	0.0012	CbGeAlD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	7.67e-05	0.000878	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—esophageal cancer	7.63e-05	0.000873	CcSEcCtD
Ibuprofen—Confusional state—Methotrexate—esophageal cancer	7.46e-05	0.000854	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methotrexate—esophageal cancer	7.4e-05	0.000847	CcSEcCtD
Ibuprofen—Infection—Methotrexate—esophageal cancer	7.35e-05	0.000842	CcSEcCtD
Ibuprofen—Hypersensitivity—Capecitabine—esophageal cancer	7.33e-05	0.000838	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—esophageal cancer	7.26e-05	0.000831	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—esophageal cancer	7.25e-05	0.000829	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—esophageal cancer	7.19e-05	0.000823	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—esophageal cancer	7.16e-05	0.000819	CcSEcCtD
Ibuprofen—Asthenia—Capecitabine—esophageal cancer	7.13e-05	0.000816	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—esophageal cancer	7.06e-05	0.000807	CcSEcCtD
Ibuprofen—Pruritus—Capecitabine—esophageal cancer	7.03e-05	0.000805	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—esophageal cancer	6.92e-05	0.000792	CcSEcCtD
Ibuprofen—Diarrhoea—Capecitabine—esophageal cancer	6.8e-05	0.000779	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—esophageal cancer	6.74e-05	0.000772	CcSEcCtD
Ibuprofen—Insomnia—Methotrexate—esophageal cancer	6.69e-05	0.000766	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—esophageal cancer	6.65e-05	0.000761	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—esophageal cancer	6.6e-05	0.000755	CcSEcCtD
Ibuprofen—Somnolence—Methotrexate—esophageal cancer	6.58e-05	0.000753	CcSEcCtD
Ibuprofen—Dizziness—Capecitabine—esophageal cancer	6.57e-05	0.000753	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—esophageal cancer	6.52e-05	0.000746	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—esophageal cancer	6.43e-05	0.000736	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—esophageal cancer	6.39e-05	0.000731	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—esophageal cancer	6.38e-05	0.00073	CcSEcCtD
Ibuprofen—Vomiting—Capecitabine—esophageal cancer	6.32e-05	0.000724	CcSEcCtD
Ibuprofen—Rash—Capecitabine—esophageal cancer	6.27e-05	0.000718	CcSEcCtD
Ibuprofen—Dermatitis—Capecitabine—esophageal cancer	6.26e-05	0.000717	CcSEcCtD
Ibuprofen—Headache—Capecitabine—esophageal cancer	6.23e-05	0.000713	CcSEcCtD
Ibuprofen—Feeling abnormal—Methotrexate—esophageal cancer	6.1e-05	0.000698	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—esophageal cancer	6.05e-05	0.000693	CcSEcCtD
Ibuprofen—Nausea—Capecitabine—esophageal cancer	5.91e-05	0.000676	CcSEcCtD
Ibuprofen—Urticaria—Methotrexate—esophageal cancer	5.88e-05	0.000673	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—esophageal cancer	5.85e-05	0.00067	CcSEcCtD
Ibuprofen—Hypersensitivity—Methotrexate—esophageal cancer	5.45e-05	0.000624	CcSEcCtD
Ibuprofen—Asthenia—Methotrexate—esophageal cancer	5.31e-05	0.000608	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—esophageal cancer	5.24e-05	0.000599	CcSEcCtD
Ibuprofen—Diarrhoea—Methotrexate—esophageal cancer	5.06e-05	0.00058	CcSEcCtD
Ibuprofen—Dizziness—Methotrexate—esophageal cancer	4.89e-05	0.00056	CcSEcCtD
Ibuprofen—Vomiting—Methotrexate—esophageal cancer	4.71e-05	0.000539	CcSEcCtD
Ibuprofen—Rash—Methotrexate—esophageal cancer	4.67e-05	0.000534	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—esophageal cancer	4.66e-05	0.000534	CcSEcCtD
Ibuprofen—Headache—Methotrexate—esophageal cancer	4.64e-05	0.000531	CcSEcCtD
Ibuprofen—Nausea—Methotrexate—esophageal cancer	4.4e-05	0.000503	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—KDR—esophageal cancer	5.51e-06	4.58e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ABCB1—esophageal cancer	5.5e-06	4.57e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—NOS2—esophageal cancer	5.48e-06	4.56e-05	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—PIK3CA—esophageal cancer	5.48e-06	4.55e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.46e-06	4.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GAPDH—esophageal cancer	5.45e-06	4.53e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CDKN1A—esophageal cancer	5.43e-06	4.51e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GAPDH—esophageal cancer	5.42e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CRABP1—esophageal cancer	5.4e-06	4.49e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ALOX15—esophageal cancer	5.39e-06	4.48e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HIF1A—esophageal cancer	5.37e-06	4.47e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CRABP1—esophageal cancer	5.37e-06	4.46e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—TYMP—esophageal cancer	5.31e-06	4.41e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—CYP19A1—esophageal cancer	5.31e-06	4.41e-05	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—TP53—esophageal cancer	5.3e-06	4.41e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ENO1—esophageal cancer	5.27e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PTGS1—esophageal cancer	5.27e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTO1—esophageal cancer	5.27e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—TPI1—esophageal cancer	5.27e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PSME2—esophageal cancer	5.2e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PSME1—esophageal cancer	5.2e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—NOTCH1—esophageal cancer	5.19e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—PIK3CA—esophageal cancer	5.19e-06	4.31e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP26A1—esophageal cancer	5.17e-06	4.29e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—EP300—esophageal cancer	5.16e-06	4.29e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—TPI1—esophageal cancer	5.14e-06	4.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTO1—esophageal cancer	5.14e-06	4.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GNG7—esophageal cancer	5.14e-06	4.27e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GNG7—esophageal cancer	5.11e-06	4.24e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ALDOB—esophageal cancer	5.05e-06	4.2e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ALOX15—esophageal cancer	5.04e-06	4.19e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.02e-06	4.17e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—NOS3—esophageal cancer	4.94e-06	4.1e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ALDOB—esophageal cancer	4.93e-06	4.1e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—CREBBP—esophageal cancer	4.92e-06	4.09e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NOS2—esophageal cancer	4.89e-06	4.06e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GAPDH—esophageal cancer	4.86e-06	4.04e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—MYC—esophageal cancer	4.85e-06	4.03e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—HMOX1—esophageal cancer	4.85e-06	4.03e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NOTCH1—esophageal cancer	4.84e-06	4.02e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CRABP1—esophageal cancer	4.82e-06	4e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ALDH2—esophageal cancer	4.81e-06	4e-05	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	4.81e-06	4e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—TPI1—esophageal cancer	4.81e-06	3.99e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTO1—esophageal cancer	4.81e-06	3.99e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ALDH2—esophageal cancer	4.79e-06	3.98e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.75e-06	3.95e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GAPDH—esophageal cancer	4.75e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—EGFR—esophageal cancer	4.74e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.74e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CREBBP—esophageal cancer	4.71e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CRABP1—esophageal cancer	4.7e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—CREBBP—esophageal cancer	4.69e-06	3.9e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TGFBR2—esophageal cancer	4.66e-06	3.87e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ABCB1—esophageal cancer	4.65e-06	3.86e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—EGFR—esophageal cancer	4.63e-06	3.85e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.62e-06	3.84e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ALDOB—esophageal cancer	4.61e-06	3.83e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GNG7—esophageal cancer	4.59e-06	3.81e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.58e-06	3.81e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTT1—esophageal cancer	4.58e-06	3.8e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTT1—esophageal cancer	4.55e-06	3.78e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYP2A6—esophageal cancer	4.53e-06	3.76e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTGS2—esophageal cancer	4.52e-06	3.75e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.51e-06	3.75e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYP2A6—esophageal cancer	4.5e-06	3.74e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CYP1B1—esophageal cancer	4.48e-06	3.72e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.48e-06	3.72e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GNG7—esophageal cancer	4.48e-06	3.72e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—CREBBP—esophageal cancer	4.44e-06	3.69e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GAPDH—esophageal cancer	4.44e-06	3.68e-05	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—PIK3CA—esophageal cancer	4.42e-06	3.67e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SMAD4—esophageal cancer	4.41e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—NOS3—esophageal cancer	4.41e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—EGFR—esophageal cancer	4.4e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CRABP1—esophageal cancer	4.4e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CREBBP—esophageal cancer	4.39e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.31e-06	3.58e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ALDH2—esophageal cancer	4.3e-06	3.57e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS1—esophageal cancer	4.29e-06	3.56e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ENO1—esophageal cancer	4.29e-06	3.56e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ENO1—esophageal cancer	4.27e-06	3.54e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS1—esophageal cancer	4.27e-06	3.54e-05	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.26e-06	3.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PSME1—esophageal cancer	4.23e-06	3.51e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PSME2—esophageal cancer	4.23e-06	3.51e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—NOS3—esophageal cancer	4.22e-06	3.5e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CYP19A1—esophageal cancer	4.22e-06	3.5e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PSME1—esophageal cancer	4.2e-06	3.49e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PSME2—esophageal cancer	4.2e-06	3.49e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—NOS3—esophageal cancer	4.2e-06	3.49e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ALDH2—esophageal cancer	4.19e-06	3.48e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GNG7—esophageal cancer	4.18e-06	3.47e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.16e-06	3.46e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—PIK3CA—esophageal cancer	4.11e-06	3.42e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTT1—esophageal cancer	4.09e-06	3.4e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—CREBBP—esophageal cancer	4.09e-06	3.39e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYP2A6—esophageal cancer	4.04e-06	3.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.02e-06	3.34e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—PIK3CA—esophageal cancer	4.02e-06	3.34e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTT1—esophageal cancer	3.99e-06	3.31e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—esophageal cancer	3.98e-06	3.31e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—NOS3—esophageal cancer	3.97e-06	3.3e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—ERBB2—esophageal cancer	3.94e-06	3.28e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.94e-06	3.28e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NOS3—esophageal cancer	3.93e-06	3.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.92e-06	3.25e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—HMOX1—esophageal cancer	3.85e-06	3.2e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTGS2—esophageal cancer	3.84e-06	3.19e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ENO1—esophageal cancer	3.83e-06	3.18e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS1—esophageal cancer	3.83e-06	3.18e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—PIK3CA—esophageal cancer	3.82e-06	3.17e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—CREBBP—esophageal cancer	3.81e-06	3.17e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—CREBBP—esophageal cancer	3.81e-06	3.17e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.77e-06	3.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PSME2—esophageal cancer	3.77e-06	3.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PSME1—esophageal cancer	3.77e-06	3.13e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—EP300—esophageal cancer	3.76e-06	3.12e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS1—esophageal cancer	3.74e-06	3.11e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ENO1—esophageal cancer	3.74e-06	3.11e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.73e-06	3.1e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTT1—esophageal cancer	3.73e-06	3.1e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ABCB1—esophageal cancer	3.69e-06	3.07e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.69e-06	3.07e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.68e-06	3.06e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PSME2—esophageal cancer	3.68e-06	3.06e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PSME1—esophageal cancer	3.68e-06	3.06e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—CREBBP—esophageal cancer	3.68e-06	3.05e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—ERBB2—esophageal cancer	3.68e-06	3.05e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.67e-06	3.05e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.67e-06	3.05e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—NOS3—esophageal cancer	3.66e-06	3.04e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYP1B1—esophageal cancer	3.65e-06	3.03e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTGS2—esophageal cancer	3.63e-06	3.02e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYP1B1—esophageal cancer	3.63e-06	3.01e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HIF1A—esophageal cancer	3.61e-06	3e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTGS2—esophageal cancer	3.6e-06	2.99e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.52e-06	2.92e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.49e-06	2.9e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ENO1—esophageal cancer	3.49e-06	2.9e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCND1—esophageal cancer	3.48e-06	2.9e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PSME2—esophageal cancer	3.44e-06	2.86e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PSME1—esophageal cancer	3.44e-06	2.86e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CYP19A1—esophageal cancer	3.43e-06	2.85e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—NOS3—esophageal cancer	3.41e-06	2.84e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—NOS3—esophageal cancer	3.41e-06	2.84e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CYP19A1—esophageal cancer	3.41e-06	2.83e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—MYC—esophageal cancer	3.39e-06	2.81e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CDKN1A—esophageal cancer	3.37e-06	2.8e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—EP300—esophageal cancer	3.35e-06	2.79e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTGS2—esophageal cancer	3.35e-06	2.78e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.3e-06	2.74e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—NOS3—esophageal cancer	3.29e-06	2.73e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NOS2—esophageal cancer	3.28e-06	2.73e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYP1B1—esophageal cancer	3.26e-06	2.71e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NOTCH1—esophageal cancer	3.25e-06	2.7e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EP300—esophageal cancer	3.21e-06	2.67e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—EP300—esophageal cancer	3.2e-06	2.65e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.18e-06	2.64e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CDKN1A—esophageal cancer	3.14e-06	2.61e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—HMOX1—esophageal cancer	3.13e-06	2.6e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTGS2—esophageal cancer	3.12e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTGS2—esophageal cancer	3.12e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—HMOX1—esophageal cancer	3.11e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—CREBBP—esophageal cancer	3.11e-06	2.58e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.07e-06	2.55e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CYP19A1—esophageal cancer	3.06e-06	2.54e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.05e-06	2.54e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—EP300—esophageal cancer	3.02e-06	2.51e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTGS2—esophageal cancer	3.01e-06	2.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3e-06	2.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ABCB1—esophageal cancer	3e-06	2.5e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—EP300—esophageal cancer	2.99e-06	2.48e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.99e-06	2.48e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ABCB1—esophageal cancer	2.99e-06	2.48e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.97e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CREBBP—esophageal cancer	2.95e-06	2.45e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MYC—esophageal cancer	2.8e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.79e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.79e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.79e-06	2.32e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—NOS3—esophageal cancer	2.78e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—EP300—esophageal cancer	2.78e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PIK3CA—esophageal cancer	2.78e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.74e-06	2.28e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EGFR—esophageal cancer	2.73e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—HMOX1—esophageal cancer	2.73e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.68e-06	2.23e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NOS3—esophageal cancer	2.64e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MYC—esophageal cancer	2.61e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—EP300—esophageal cancer	2.6e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—EP300—esophageal cancer	2.6e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—EGFR—esophageal cancer	2.55e-06	2.12e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.55e-06	2.12e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTGS2—esophageal cancer	2.55e-06	2.11e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—EP300—esophageal cancer	2.5e-06	2.08e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.5e-06	2.08e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—PIK3CA—esophageal cancer	2.48e-06	2.06e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CREBBP—esophageal cancer	2.47e-06	2.05e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ERBB2—esophageal cancer	2.47e-06	2.05e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.44e-06	2.03e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—esophageal cancer	2.4e-06	1.99e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PIK3CA—esophageal cancer	2.37e-06	1.97e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PIK3CA—esophageal cancer	2.36e-06	1.96e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—esophageal cancer	2.3e-06	1.91e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.27e-06	1.89e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.26e-06	1.88e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CA—esophageal cancer	2.24e-06	1.86e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CA—esophageal cancer	2.21e-06	1.84e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—NOS3—esophageal cancer	2.21e-06	1.84e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—EP300—esophageal cancer	2.12e-06	1.76e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CDKN1A—esophageal cancer	2.11e-06	1.75e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	2.06e-06	1.71e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.03e-06	1.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CREBBP—esophageal cancer	2.01e-06	1.67e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EP300—esophageal cancer	2.01e-06	1.67e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CREBBP—esophageal cancer	2e-06	1.66e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CA—esophageal cancer	1.92e-06	1.6e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CA—esophageal cancer	1.92e-06	1.6e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CA—esophageal cancer	1.85e-06	1.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.85e-06	1.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—NOS3—esophageal cancer	1.8e-06	1.49e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.79e-06	1.49e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—NOS3—esophageal cancer	1.79e-06	1.48e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CREBBP—esophageal cancer	1.75e-06	1.45e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MYC—esophageal cancer	1.75e-06	1.45e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EGFR—esophageal cancer	1.71e-06	1.42e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—EP300—esophageal cancer	1.68e-06	1.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.64e-06	1.37e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS2—esophageal cancer	1.63e-06	1.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.63e-06	1.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—NOS3—esophageal cancer	1.6e-06	1.33e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—NOS3—esophageal cancer	1.57e-06	1.3e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CA—esophageal cancer	1.57e-06	1.3e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CA—esophageal cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.47e-06	1.22e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—NOS3—esophageal cancer	1.46e-06	1.22e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS2—esophageal cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—EP300—esophageal cancer	1.37e-06	1.14e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—EP300—esophageal cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CA—esophageal cancer	1.24e-06	1.03e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—EP300—esophageal cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—EP300—esophageal cancer	1.19e-06	9.9e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—EP300—esophageal cancer	1.11e-06	9.25e-06	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.01e-06	8.4e-06	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CA—esophageal cancer	1.01e-06	8.36e-06	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CA—esophageal cancer	9.03e-07	7.5e-06	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CA—esophageal cancer	8.81e-07	7.32e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CA—esophageal cancer	8.23e-07	6.84e-06	CbGpPWpGaD
